CAT
Caterpillar Inc.
CAT has the edge over OMAB overall, supported by stronger modeled upside and stronger fundamentals.
OMAB
Grupo Aeroportuario del Centro Norte, S.A.B. de C.V.
OMAB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
OMAB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
OMAB's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
OMAB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $81.01 | -26% |
| Fair | 18x | $107 | -2.8% |
| Current | 18x | $110 | — |
| Expensive | 26x | $156 | +42% |
Historical ranges are pointers, not guarantees.
OMAB has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over OMAB on the outlook, with more favorable revenue expectations.
OMAB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect OMAB's earnings to grow and its profitability to improve, with its revenue holding steady.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
OMAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $6.05 | +3.1% |
| Q2 2026 | $6.01 | +3.4% |
| Q1 2026 | $5.81 | -1.5% |
| Q4 2025 | $5.84 | +3.4% |
| Q3 2025 | $5.87 | +3.7% |
| Q2 2025 | $5.81 | +2.5% |
| Q1 2025 | $5.90 | +6.9% |
| Q4 2024 | $5.65 | +2.5% |
OMAB has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
OMAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $257M | +22% |
| Q2 2026 | $239.7M | +2.6% |
| Q1 2026 | $204.8M | +6.9% |
| Q4 2025 | $220.7M | 0% |
| Q3 2025 | $210.8M | +6.1% |
| Q2 2025 | $233.6M | +24% |
| Q1 2025 | $191.5M | -5% |
| Q4 2024 | $220.8M | +11% |
OMAB's revenue is growing: $257M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 53% | -7.8 points |
| Q2 2026 | 53% | +0.8 points |
| Q1 2026 | 55% | -4.6 points |
| Q4 2025 | 52% | -1.3 points |
| Q3 2025 | 61% | +2.6 points |
| Q2 2025 | 53% | +108 points |
| Q1 2025 | 59% | +11 points |
| Q4 2024 | 53% | -0.6 points |
OMAB has the edge over CAT on profitability, with a higher operating margin.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
OMAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $104.5M | +39% |
| Q2 2026 | $49.4M | -24% |
| Q1 2026 | $47.6M | -19% |
| Q4 2025 | $95.4M | +0.1% |
| Q3 2025 | $75M | +38% |
| Q2 2025 | $65.1M | +33% |
| Q1 2025 | $58.7M | +6.4% |
| Q4 2024 | $95.3M | +6.4% |
OMAB has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over OMAB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
OMAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | -- |
| 5 years | -1% | -493K shares |
| Available history | -1.3% | -641K shares |
OMAB has 48M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $131,992 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
OMAB has spent almost nothing on buybacks in the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over OMAB on leverage, with a lower net debt burden relative to earnings.
OMAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.0x | Very low |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.1x | Healthy |
OMAB's net debt is about 1.1 years of its operating earnings (EBITDA), up from less than a year a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
OMAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.5 | Neutral |
| Stochastic | 79.8 | Neutral |
OMAB's weekly RSI is 56 (neutral) and its Stochastic is 80 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
OMAB PE vs Industrials Sector
| Metric | OMAB | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 25% below |
| PE % | 58 | 58 | Same percentile |
OMAB has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
OMAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.0 | 9.8% above |
| 20 week MA | $102.4 | 7.2% above |
| 50 week MA | $108.0 | 1.6% above |
| 100 week MA | $101.0 | 8.7% above |
| 200 week MA | $88.9 | 23% above |
OMAB has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over OMAB on returns for 2026, with the stronger performance.
OMAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.9 | $51.1 | -16% |
| 2021 | $51.1 | $53.0 | +3.6% |
| 2022 | $53.0 | $65.6 | +24% |
| 2023 | $65.6 | $84.6 | +29% |
| 2024 | $84.6 | $69.6 | -18% |
| 2025 | $69.6 | $112.8 | +62% |
| 2026 YTD | $112.8 | $109.8 | -2.7% |
OMAB has finished higher in four of the last six years. It's down 2.7% so far in 2026.